Literature DB >> 16952881

Elastic vesicles as a tool for dermal and transdermal delivery.

P Loan Honeywell-Nguyen1, H W Wouter Groenink, Joke A Bouwstra.   

Abstract

The main problem in delivery of drugs across the skin is the barrier function of the skin, which is located in the outermost layer of the skin, the stratum corneum. The stratum corneum consists of corneocytes surrounded by lipid layers, the so-called lipid lamellae. When applying drugs onto the skin, the major penetration pathway is the tortuous intercellular route along the lipid lamellae. In order to increase the number of drugs administered via the transdermal route, novel drug delivery systems have to be designed. Among these systems are iontophoresis, electroporation, microneedles, and vesicular systems.

Entities:  

Mesh:

Year:  2006        PMID: 16952881     DOI: 10.1080/08982100600848595

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  4 in total

1.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Vivek Gupta; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

2.  Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.

Authors:  Man Ma; Jinping Wang; Fang Guo; Mingzhu Lei; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-05-20       Impact factor: 3.896

3.  Effect of Penetration Enhancer Containing Vesicles on the Percutaneous Delivery of Quercetin through New Born Pig Skin.

Authors:  Maura Chessa; Carla Caddeo; Donatella Valenti; Maria Manconi; Chiara Sinico; Anna Maria Fadda
Journal:  Pharmaceutics       Date:  2011-08-12       Impact factor: 6.321

4.  Superresolution and Fluorescence Dynamics Evidence Reveal That Intact Liposomes Do Not Cross the Human Skin Barrier.

Authors:  Jes Dreier; Jens A Sørensen; Jonathan R Brewer
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.